PENN123i-SV20
**Upon testing, the current lot of material did not meet WiCell`s standards for quality, and it is therefore unavailable. WiCell is working with the Provider to obtain replacement materials for distribution. To be notified of the status of this cell line please submit your information here.| Cell Line Alias | iPS-SV20 |
| Cell Type | Human iPS |
| Disease | None reported |
| Sex | Male |
| Age at Collection | 43 Years |
| Ethnicity | Caucasian |
| Ethnicity Information | Self-reported |
| Genetically Related Cell Lines | |
| Reprogramming Method | Non-integrating (Sendai: Oct4, Klf4, Sox2, cMyc) |
| Tissue Origin | Blood |
| Provider | University of Pennsylvania - Dr. Daniel Rader |
| dbGaP Data | |
| hPSCReg ID | |
| NIH Approval | |
| Pub Med Abstract | |
| Collection(s) | NHLBI Next Gen - Lipid Conditions (Dr. Daniel Rader, University of Pennsylvania) |
Current Lot Information
| Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
|---|---|---|---|---|---|---|
| DB36624 | mTeSR1/Matrigel | 26(9) | Provider | WiCell Feeder Independent Pluripotent Stem Cell Protocol |
